Abstract:Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Romanian Ministry of National Education, CNCS-UEFISCDI. Background Atrial fibrillation (AF) is the most frequent arrhythmia in hypertrophic cardiomyopathy (HCM), with a major impact on overall survival, thromboembolic risk, and quality of life. Early recognition and treatment of AF are essential to improve the outcome of HCM patients (pts). Despite the existence of several independent predictors of AF development, the identification of HCM pts at risk for AF is still inconsistent. The identification, quantification, and interpretation of the relationships between different clinical and imaging-derived variables may lead to improved risk stratification and prognosis. Predictive models based on machine learning (ML) could reduce variability while providing useful new medical knowledge. Purpose Develop a ML model (emerging from the integration of clinical and echocardiographic data) capable of accurately detecting HCM pts with AF. Methods A comprehensive clinical and echocardiographic assessment was performed in 151 consecutive pts (52±16 years, 72 men) with HCM, in sinus rhythm. Pts were divided into two groups according to the presence (38 pts) or absence (113 pts) of documented paroxysmal AF (24/48 h ambulatory ECG recordings). 81 features (clinical and echocardiographic parameters) were considered as input to the ML models. Four different ML models were evaluated: Deep Learning (DL), Linear Logistic Regression (LLR), Support Vector Machine (SVM) and Random Forest (RF). Ensemble learning and four-fold cross-validation were employed in all experiments. For each experiment the training dataset was augmented and balanced using the Synthetic Minority Over-sampling Technique. The models were fine-tuned using the following hyper-parameters: learning rate, batch size, number of hidden layers, and number of features used as input. The features were first ranked using the Recursive Feature Elimination method, and the top N features were selected during the hyper-parameter tuning. Results Each ML model was trained for 100 epochs, and the results were extracted from the epoch that led to the best results when combining all four folds. DL was the best performing model, with a learning rate of 0.01, a batch size of 32, 4 hidden layers (256/128/128/64 neurons), and 15 input features. The DL model had 5% higher accuracy compared to LLR, 10% higher than SVM and 8% higher than RF, with consistently higher sensitivity. The performance of the various models is detailed in the table below. Moreover, the DL model had significantly higher accuracy compared to conventional imaging parameters consistently related to the presence of AF in previous studies, such as maximum LA volume (AUC 0.66, accuracy 59%) or LA strain (AUC 0.61, accuracy 62%). Conclusions The DL based model can detect the presence of paroxysmal AF in patients with HCM with an accuracy of 84% (5% higher than the best classic ML model, and significantly higher than independent conventional imaging parameters).

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy

Deep Learning-Derived 12-Lead Electrocardiogram-Based Genotype Prediction for Hypertrophic Cardiomyopathy: a Pilot Study.

Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events

A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy

Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model

Prediction of Left Ventricular Ejection Fraction Changes in Heart Failure Patients Using Machine Learning and Electronic Health Records: a Multi-Site Study.

Abstract 9715: Feasibility of Using Machine Learning to Establish a Risk Prediction Model for Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy(HCM-VAr-Risk Model)

Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy

Machine learning in the prevention of heart failure

Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram

Predicting Heart Failure Survival with Machine Learning: Assessing My Risk

A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data

Multi‐modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45%

A Phenotyping of Diastolic Function by Machine Learning Improves Prediction of Clinical Outcomes in Heart Failure

Abstract 16723: A Machine Learning Approach to Acute Heart Failure Risk Stratification

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy

Machine learning model to predict the presence of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy

Using Machine Learning to Predict One-Year Cardiovascular Events in Patients with Severe Dilated Cardiomyopathy.

Machine learning can identify hypertrophic cardiomyopathy in pediatric patients using electrocardiogram